Search research articles
Contact Us
Filters
Showing results (451-460 of 462) with videos related to
Page
of 47
Sort By:
American Heart Journal
|
November 4, 2020
Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial
Zachary L Cox, Sean P Collins, Mark Aaron, et al.
Journal of the American College of Cardiology
|
April 3, 2024
Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure
Zachary L Cox, Sean P Collins, Gabriel A Hernandez, et al.
International Clinical Psychopharmacology
|
February 4, 2015
A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military Veterans resistant to antidepressant treatment
Jennifer C Naylor, Jason D Kilts, Daniel W Bradford, et al.
American Journal of Cancer Research
|
June 24, 2015
Melanoma patient derived xenografts acquire distinct Vemurafenib resistance mechanisms
David J Monsma, David M Cherba, Emily E Eugster, et al.
Nature
|
August 14, 2020
cDC1 prime and are licensed by CD4<sup>+</sup> T cells to induce anti-tumour immunity
Stephen T Ferris, Vivek Durai, Renee Wu, et al.
Cell Reports
|
February 7, 2019
Respiratory Phenomics across Multiple Models of Protein Hyperacylation in Cardiac Mitochondria Reveals a Marginal Impact on Bioenergetics
Kelsey H Fisher-Wellman, James A Draper, Michael T Davidson, et al.
Science (New York, N.Y.)
|
November 10, 2018
WDFY4 is required for cross-presentation in response to viral and tumor antigens
Derek J Theisen, Jesse T Davidson, Carlos G Briseño, et al.
Nature Immunology
|
August 14, 2019
Cryptic activation of an Irf8 enhancer governs cDC1 fate specification
Vivek Durai, Prachi Bagadia, Jeffrey M Granja, et al.
Journal of Surgical Oncology
|
December 29, 2017
Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: A multi-institution analysis from the U.S. extrahepatic biliary malignancy consortium
Bradley A Krasnick, Linda X Jin, Jesse T Davidson, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
November 25, 2017
Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortium
Gregory V Schimizzi, Linda X Jin, Jesse T Davidson, et al.
Page
of 47
Search research articles
Search
Showing results (451-460 of 462) with videos related to
Sort By:
Page
of 47
American Heart Journal
|
November 4, 2020
Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial
Zachary L Cox, Sean P Collins, Mark Aaron, et al.
Journal of the American College of Cardiology
|
April 3, 2024
Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure
Zachary L Cox, Sean P Collins, Gabriel A Hernandez, et al.
International Clinical Psychopharmacology
|
February 4, 2015
A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military Veterans resistant to antidepressant treatment
Jennifer C Naylor, Jason D Kilts, Daniel W Bradford, et al.
American Journal of Cancer Research
|
June 24, 2015
Melanoma patient derived xenografts acquire distinct Vemurafenib resistance mechanisms
David J Monsma, David M Cherba, Emily E Eugster, et al.
Nature
|
August 14, 2020
cDC1 prime and are licensed by CD4<sup>+</sup> T cells to induce anti-tumour immunity
Stephen T Ferris, Vivek Durai, Renee Wu, et al.
Cell Reports
|
February 7, 2019
Respiratory Phenomics across Multiple Models of Protein Hyperacylation in Cardiac Mitochondria Reveals a Marginal Impact on Bioenergetics
Kelsey H Fisher-Wellman, James A Draper, Michael T Davidson, et al.
Science (New York, N.Y.)
|
November 10, 2018
WDFY4 is required for cross-presentation in response to viral and tumor antigens
Derek J Theisen, Jesse T Davidson, Carlos G Briseño, et al.
Nature Immunology
|
August 14, 2019
Cryptic activation of an Irf8 enhancer governs cDC1 fate specification
Vivek Durai, Prachi Bagadia, Jeffrey M Granja, et al.
Journal of Surgical Oncology
|
December 29, 2017
Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: A multi-institution analysis from the U.S. extrahepatic biliary malignancy consortium
Bradley A Krasnick, Linda X Jin, Jesse T Davidson, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
November 25, 2017
Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortium
Gregory V Schimizzi, Linda X Jin, Jesse T Davidson, et al.
Page
of 47